RecruitingNot ApplicableNCT06910631

Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care

Optimisation du Parcours de Soins Des Enfants fébriles Par l'Utilisation de la CRP Capillaire en Soins Primaires : Protocole d'un Essai Multicentrique randomisé


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

420 participants

Start Date

Sep 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Fever is the leading reason for outpatient consultations among children aged 2 to 9 years. The main concern in fever is severe bacterial infection, particularly for younger children. History and clinical examination do not always differentiate viral infections from bacterial infection. In 20% of febrile children, no infectious focus is found after examination and additional tests are necessary. The first one is measuring C-reactive protein (CRP). The results are obtained in several hours on an outpatient basis, causing long delays before starting treatment and often requiring telephone calls or further consultations. Emergency room use is constantly increasing, generating growing tensions within healthcare facilities, yet a large number of visits are avoidable. Among children visiting the pediatric emergency room, parents reported being referred by their primary care physician in approximately 20% of cases for children aged 1 to 5 years and in 30% of cases for children under one year old. The use of capillary medical device to measure CRP in primary care could reduce this referral rate and help relieve overcrowding in emergency rooms, as well as unscheduled consultation centers and medical analysis laboratories. This would result in a streamlined care pathway, saving time for both physicians and patients, as well as reducing the cost of care for the healthcare system.


Eligibility

Min Age: 3 MonthsMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Capillary CRP for people with fever. The study is currently recruiting participants at 37 locations. People eligible for this study include aged 3 Months to 15 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCapillary CRP

CRP measured semi-quantitatively using ACTIM-CRP device


Locations(37)

Centre médical du Grau D'Agde

Agde, France

Cabinet Medical Baho

Baho, France

MSP OLEA

Bezouce, France

Msp Balmat Sante

Béziers, France

MSP Espace Santé Servian

Béziers, France

Msp Madeleine Bres

Bouillargues, France

MSP Terre de Béliers

Bouillargues, France

MSPU Avicenne

Cabestany, France

MSP de Calvisson

Calvisson, France

MSP de Clarensac

Caveirac, France

Msp Au Fil de L'Hers

Deyme, France

Msp Gigean

Gigean, France

Cds de Ma Region

Le Vigan, France

Msp Le Cube

Montgiscard, France

MMG de Montpellier

Montpellier, France

Msp La Mosson

Montpellier, France

MSP Montpellier-Cévennes

Montpellier, France

MMG de Narbonne

Narbonne, France

Msp Narbo-Ouest

Narbonne, France

CHU de Nîmes

Nîmes, France

MMG de Nîmes

Nîmes, France

MSP Charles GIDE

Nîmes, France

CABINET MEDICAL Perpignan

Perpignan, France

CABINET médical de l'Étang de l'Or

Pérols, France

Mspu Pins Justaret

Pins-Justaret, France

MSP de Pont Saint Esprit

Pont-Saint-Esprit, France

MSPU Pauline Lautaud

Prades-le-Lez, France

MSP Le Prisme

Remoulins, France

Msp Du Thaurac

Saint-Bauzille-de-Putois, France

CABINET MEDICAL Saint-Hippolyte-du-Fort

Saint-Hippolyte-du-Fort, France

Msp Saint Jean-Du Gard

Saint-Jean-du-Gard, France

MSP Saint-Laurent d'Aigouze

Saint-Laurent-d'Aigouze, France

MSP Sud Minervois

Saint-Marcel-sur-Aude, France

CDS Filieris Saint Martin de Valgalgues

Saint-Martin-de-Valgalgues, France

Maison de santé de St Quentin la Poterie

Saint-Quentin-la-Poterie, France

MSP Pezenas Tourbes

Tourbes, France

Mspu La Source

Vergèze, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06910631


Related Trials